The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The prognostic role of XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms (SNPs) in resected non-small cell lung cancer (NSCLC).
Caglayan Geredeli
No relevant relationships to disclose
Mehmet Artac
No relevant relationships to disclose
Selman Yildirim
No relevant relationships to disclose
Isa Dede
No relevant relationships to disclose
Ali Inal
No relevant relationships to disclose
Tunc Guler
No relevant relationships to disclose
Melih Cem Boruban
No relevant relationships to disclose
Ayse Gul Zamani
No relevant relationships to disclose
Hakan Bozcuk
No relevant relationships to disclose
Ahmet Demirkazik
No relevant relationships to disclose